William Abramovits

Cost of atopic dermatitis and eczema in the United States

Charles N. Ellis, Lynn A. Drake, Mary M. Prendergast et al. · Journal of the American Academy of Dermatology · 2002 · 213 citations

Medicine, Dermatology, Pharmacoeconomics +9

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Andrew Blauvelt, Kim Papp, Alice B. Gottlieb et al. · British Journal of Dermatology · 2019 · 172 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +15

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles

Neil A. Swanson, William Abramovits, Brian Berman et al. · Journal of the American Academy of Dermatology · 2010 · 149 citations

Medicine, Dermatology, Ophthalmology +7

Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: A randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle

Debra Breneman, Alan B. Fleischer, William Abramovits et al. · Journal of the American Academy of Dermatology · 2008 · 112 citations

Medicine, Dermatology, Pharmacotherapy +17

Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study

David M. Pariser, Robert W. Loss, Michael Jarratt et al. · Journal of the American Academy of Dermatology · 2008 · 106 citations

Medicine, Dermatology, Ophthalmology +12